» Articles » PMID: 30755532

Inhibition of EZH2 Prevents Fibrosis and Restores Normal Angiogenesis in Scleroderma

Overview
Specialty Science
Date 2019 Feb 14
PMID 30755532
Citations 51
Authors
Affiliations
Soon will be listed here.
Abstract

Scleroderma (SSc) is a complex disease that involves activation of the immune system, vascular complications, and tissue fibrosis. The histone methyltransferase enhancer of zeste homolog 2 (EZH2) mediates trimethylation of lysine 27 of histone 3 (H3K27me3), which acts as a repressive epigenetic mark. Both EZH2 and H3K27me3 were elevated in SSc dermal fibroblasts and endothelial cells compared with healthy controls. EZH2 inhibitor DZNep halted fibrosis both in vitro and in vivo. In SSc fibroblasts, DZNep dose-dependently reduced the expression of profibrotic genes and inhibited migratory activity of SSc fibroblasts. We show that epigenetic dysregulation and overexpression of LRRC16A explains EZH2-mediated fibroblast migration in SSc. In endothelial cells, inhibition of EZH2 restored normal angiogenesis in SSc via activating the Notch pathway, specifically by up-regulating the Notch ligand DLL4. Our results demonstrate that overexpression of EZH2 in SSc fibroblasts and endothelial cells is profibrotic and antiangiogenic. Targeting EZH2 or EZH2-regulated genes might be of therapeutic potential in SSc.

Citing Articles

Epigenetic Regulation in Myocardial Fibroblasts and Its Impact on Cardiovascular Diseases.

Komal S, Gao Y, Wang Z, Yu Q, Wang P, Zhang L Pharmaceuticals (Basel). 2024; 17(10).

PMID: 39458994 PMC: 11510975. DOI: 10.3390/ph17101353.


Targeting CD13/Aminopeptidase N as a Novel Therapeutic Approach for Scleroderma Fibrosis.

Muraoka S, Brodie W, Mattichak M, Gurrea-Rubio M, Ikari Y, Foster C Arthritis Rheumatol. 2024; 77(1):80-91.

PMID: 39175116 PMC: 11684996. DOI: 10.1002/art.42973.


EZH2 as a major histone methyltransferase in PDGF-BB-activated orbital fibroblast in the pathogenesis of Graves' ophthalmopathy.

Visamol S, Palaga T, Saonanon P, Pruksakorn V, Hirankarn N, van Hagen P Sci Rep. 2024; 14(1):7947.

PMID: 38575707 PMC: 10994939. DOI: 10.1038/s41598-024-57926-x.


Recent Insights into the Role of DNA Methylation and Histone Modifications in Systemic Sclerosis: A Scoping Review.

Kostova T, Karalilova R, Batalov Z, Kazakova M, Sarafian V, Batalov A Diagnostics (Basel). 2024; 14(6).

PMID: 38535072 PMC: 10969595. DOI: 10.3390/diagnostics14060652.


O-GlcNAc regulates anti-fibrotic genes in lung fibroblasts through EZH2.

Wu Q, Vang S, Zhou J, Krick S, Barnes J, Sanders Y J Cell Mol Med. 2024; 28(7):e18191.

PMID: 38494860 PMC: 10945079. DOI: 10.1111/jcmm.18191.


References
1.
van der Vlag J, Otte A . Transcriptional repression mediated by the human polycomb-group protein EED involves histone deacetylation. Nat Genet. 1999; 23(4):474-8. DOI: 10.1038/70602. View

2.
Yang C, Pring M, Wear M, Huang M, Cooper J, Svitkina T . Mammalian CARMIL inhibits actin filament capping by capping protein. Dev Cell. 2005; 9(2):209-21. PMC: 2628720. DOI: 10.1016/j.devcel.2005.06.008. View

3.
Vire E, Brenner C, Deplus R, Blanchon L, Fraga M, Didelot C . The Polycomb group protein EZH2 directly controls DNA methylation. Nature. 2005; 439(7078):871-4. DOI: 10.1038/nature04431. View

4.
Wang Y, Fan P, Kahaleh B . Association between enhanced type I collagen expression and epigenetic repression of the FLI1 gene in scleroderma fibroblasts. Arthritis Rheum. 2006; 54(7):2271-9. DOI: 10.1002/art.21948. View

5.
Lu C, Bonome T, Li Y, Kamat A, Han L, Schmandt R . Gene alterations identified by expression profiling in tumor-associated endothelial cells from invasive ovarian carcinoma. Cancer Res. 2007; 67(4):1757-68. DOI: 10.1158/0008-5472.CAN-06-3700. View